Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort

BACKGROUND: With regard to switching tumor necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA), conflicting results have been reported as to whether the effectiveness of a second TNFi depends on the reason for discontinuation of the first TNFi. METHODS: Patients with a clinical diag...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Arthritis Res Ther
Glavni autori: Ciurea, Adrian, Exer, Pascale, Weber, Ulrich, Tamborrini, Giorgio, Steininger, Beate, Kissling, Rudolf O., Bernhard, Jürg, Scherer, Almut
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802885/
https://ncbi.nlm.nih.gov/pubmed/27000865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0969-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items